简介：用量子化学B3LYP/6-311＋G（d,p）方法优化了H2ClCS单分子分解反应驻点物种的几何构型,并在相同水平上通过频率计算和内禀反应坐标（IRC）分析对过渡态结构及连接性进行了验证.用QCISD（T）/6-311＋＋G（d,p）方法计算各物种的单点能,并对总能量进行了零点能校正.利用经典过渡态理论（TST）与变分过渡态理论（CVT）并结合小曲率隧道效应模型（SCT）,计算了主反应通道在200K～2000K温度范围内的速率常数kTST,kCVT和kCVT/SCT.结果表明,H2ClCS存在8条可能的裂解通道,可生成产物P1（HCS＋HCl）,P2（CSH＋HCl）,P3（H2S＋CCl）和P4（ClHCS＋H）.所有反应均为吸热反应.相对于H2ClCS,各产物能量分别为60.9,222.9,275.7和156.9kJ.mol-1.通道H2ClCS→TS3→P1的反应势垒为81.5kJ.mol-1,是标题反应的主反应通道,其余通道为次反应通道.在200K～2000K温度区间内得到主反应通道的表观反应速率常数三参数表达式为.kCVT/SCT=8.7610T0.79exp（-4053.6/T）s-1.
简介：AbstractObjective:The aim of this work was to explore the feasibility of in vivo and non-invasive monitoring of deuterium/hydrogen (2H/1H) exchange at the metabolic level upon exposure to heavy water (2H2O).Methods:The healthy female mice were randomly assigned to two groups after day 0 when both mice received standard drinking water. The treated mouse was fed with 2H2O (80%, v/v) and the control mouse fed with standard drinking water (H2O) over next 13 days. Real-time mass spectrometric analysis of volatile metabolism emitted through breathing and the skin was performed on days 1, 2, 3, 10, 12, and 13. Animal experiment was approved by the Laboratory Animal Ethics Committee of Jinan University (approval No. 20161117163322) on October 29, 2021.Results:We observed a replacement of 1H by 2H in 52 mass spectral features (60 2H/1H isotopologue pairs) for the mouse fed with 2H2O, but not for the control mouse. These included pyruvic acid and lactic acid, lysine and methyl-lysine as well as short-chain fatty acids comprising acetic acid, propionic acid, butyric acid and valeric acid.Conclusion:Secondary electrospray ionization-high resolution mass spectrometry allows monitoring in vivo2H-incorporation of metabolites in a non-invasive and real-time setup and opens new opportunities to use 2H tracing to extend current metabolic studies, especially those with a focus on anaerobic glycolysis, lysine methylation and gut microbiome via monitoring of short-chain fatty acids.
简介：无
简介：Thesolidaddofthefirstprotonatedzincoborophosphate,(H3O)Zn(H2O)2BP2O8·H2O(1),wassoventothermallysyn-thesizedbythereactionofZn(NO3)2·6H2OandH3BO3withH3PO4inamixedsolvent,andstructurallycharacterizedbysingle-ystalX-raydiffractionanalysis.ItcrystallizesinthehexagonalP6122,a=0.9604(4)nm,c=1.5297(6)nm,V=1.2218(8)nm^3,Dc=2.921g/cm^3,Z=6,F(000)=1080,μ=3.495mm^-1.Thestmchwefeaturesthatthetetrahedra-te-trahedrahdlcesinterconnectedbyoctahedraandstronghydro-gembondinteractionsformathree-dimensionalframework.Theprotonatedwatermoleculesarelocatedatuniquepositions.othercharacterizationsbyIRandthermalanalysisarealsode-scribed.
简介：BackgroundTaxifolin(Tax)isanessentialnaturalantioxidant.MultiplestudieshaveshownthatTaxcanprotectcardiomyocytesfromischemia-reperfusioninjury.However,theunderlyingmechanismisstillunclear.MethodsH9C2cellswererandomlydividedintocontrol,H_2O_2group,Taxpretreatmentgroup(Tax+H_2O_2);Taxeffectgroup.CellactivitywasdetectedbyCCK-8andtheintracellularstructurewasobservedbytransmissionelectronmicroscopy.AutophagywasdeterminebyWesternblottinganalysisofBeclin-1,Bcl-2andPKC.ResultsTaxpretreatmentsignificantlyincreasedanti-apoptoticproteinBcl-2andautophagyproteinBeclin-1.ExpressionofPKCwasinhibitedbyTax.ConclusionsTaxpretreatmentcouldprotectH9C2cellsagainstH_2O_2-induceddamagethroughtheBcl-2andautophagypathways.
简介：本文报道了Ｃ６Ｈ１２Ｏ６（ＮＨ４）２ＳＯ４Ｃ２Ｈ５ＯＨＨ２Ｏ（Ｃ２Ｈ５ＯＨ／Ｈ２Ｏ＝０．９０）体系在３５℃时体系溶解度和饱和溶液的折光指数，并绘出了体系相应的溶度图和饱和溶液的折光指数曲线图。结果表明：所研究的体系为四元体系Ｃ６Ｈ１２Ｏ６（ＮＨ４）２ＳＯ４Ｃ２Ｈ５ＯＨＨ２Ｏ中的一部分。当溶液中肌醇饱和时，溶度曲线落在约５０％的等醇水比面上。当（ＮＨ４）２ＳＯ４在溶液中达到饱和时，出现共饱点。其组成为（ＮＨ４）２ＳＯ４：２１０％，Ｃ６Ｈ１２Ｏ６：２．０８％，Ｃ２Ｈ５ＯＨ：４４７５％。同时出现分层，在富醇相随着乙醇浓度的增加，出现肌醇与硫酸铵共饱线。在富水相硫酸铵饱和溶度曲线落在约５％乙醇的等醇水比面上，折光指数曲线由三支组成，其中两条分别与Ｃ６Ｈ１２Ｏ６·Ｈ２Ｏ和（ＮＨ４）２ＳＯ４相对应，另外一条线与（ＮＨ４）２ＳＯ４和Ｃ６Ｈ１２Ｏ６·Ｈ２Ｏ的共饱线相对应
简介：AsimplespectrophotometricassayofH2O2andglucoseusingAgnanoparticleshasbeencarriedout.RelyingonthesynergisticeffectofH2O2reductionandultraviolet(UV)irradiation,Agnanoparticleswithenhancedabsorptionsignalsweresynthesized.H2O2servedasareducingagentintheAgnanoparticlesformationinwhichAg+wasreducedtoAg0byO2àgeneratedviathedecompositionofH2O2inalkalinemedia.Ontheotherhand,photoreductionofAg+toAg0underUVirradiationsalsocontributedtothenanoparticlesformation.ThesynthesizednanoparticleswerecharacterizedbyTEM,XPS,andXRD.TheproposedmethodcoulddetermineH2O2withconcentrationsrangingfrom5.010à7to6.010à5mol/L.Thedetectionlimitwasestimatedtobe2.010à7mol/L.SincetheconversionofglucosetogluconicacidcatalyzedbyglucoseoxidasewascompaniedwiththeformationofH2O2,thesensingprotocolhasbeensuccessfullyutilizedforthedeterminationofglucoseinhumanbloodsamples.Theresultswereingoodagreementwiththosedeterminedbyalocalhospital.Thiscolorimetricsensorthusholdsgreatpromisesinclinicalapplications.
简介：Thecopper(Ⅱ）complex[Cu3(nta)2(azpy)2(H2O2)]·6H2O(nta=nitrilotriacetate,azpy=4,4′-azobispyridine)hasbeensynthesizedandcharacterized.TheX-rayanalysisrevealsthattherearetwokindsofcopper(Ⅱ）coordinationenvironments.Cu(1)hasadistortedsquareplanesymmetryandCu(2)hasadistortedoctahedralsymmetry.Cu(1)islinkedtoCu(2)throughntaandboundtoCu(1C)byazpy,andCu(2)islinkedtoCu(2A)throughazpy,whichextendstotwo-dimensionalnetworkwithlargerhombus1.2nm×1.7nm.
简介：Newmodelcompound1H,1′H-Bis（benz-Δ^4-imidazoline)2,2′-spiro-titaniumdichloridewaspreparedandthestructureofthecompoundwasdeterminedby1R,MSandelementaryanalysis.
简介：对化合物[Na_2（H_2O）_（10）][Cu_4（H_2O）_（12）（H_2W_（12）O_（42））]·15H_2O（简称Na_2Cu_4W_（12））进行了体外抗肿瘤活性研究.应用四甲基偶氮唑盐（3-[4,5-dimethylthiazo-2-y]-2,5-diphenyltetrazoliumbromide,MTT）比色法分析Na_2Cu_4W_（12）对人肝癌细胞（HepG2）、人神经母细胞瘤细胞（SHY5Y）增殖抑制活性.采用光学显微镜观察肿瘤细胞的凋亡形态变化,用流式细胞术分析细胞周期和细胞凋亡,计算各期细胞比例及细胞凋亡率.结果表明,Na_2Cu_4W_（12）对HepG2和SHY5Y2种肿瘤细胞增殖半数抑制浓度IC_（50）值分别为5.3和10.2μmol·L~（-1）,且呈剂量依赖性.光学显微镜下处理组细胞出现皱缩、变圆、缩小等形态变化,不同浓度Na_2Cu_4W_（12）处理12h早期凋亡细胞所占的百分比显著增加且呈剂量依赖性.综上所述,Na_2Cu_4W_（12）能够抑制胞瘤细胞增殖,诱导细胞凋亡.
客服QQ：30444492琼网文【2021】1550-113号
增值电信业务经营许可证：琼B2-20210322
出版物经营许可证：新出发龙华出字第(2021)009号
广播电视节目制作经营许可证：(琼)字第00779号
版权所有 ©2002-2024 期刊网(www.qikanchina.com) 琼ICP备2021005105号
![Crystal Structure and Bioactivity of Complex [Gd（C10<b style='color:red'>H</b>9N<b style='color:red'>2</b>O4）（C10<b style='color:red'>H</b>8N<b style='color:red'>2</b>O4）（<b style='color:red'>H</b><b style='color:red'>2</b>O）3]<b style='color:red'>2</b>·phen·4<b style='color:red'>H</b><b style='color:red'>2</b>O](/image/thesis9 "Crystal Structure and Bioactivity of Complex [Gd（C10<b style='color:red'>H</b>9N<b style='color:red'>2</b>O4）（C10<b style='color:red'>H</b>8N<b style='color:red'>2</b>O4）（<b style='color:red'>H</b><b style='color:red'>2</b>O）3]<b style='color:red'>2</b>·phen·4<b style='color:red'>H</b><b style='color:red'>2</b>O")
![Synthesis,Structure and Characterization of Two—dimensional Network Copper Complex [Cu3（nta）<b style='color:red'>2</b>（azpy）<b style='color:red'>2</b>（<b style='color:red'>H</b><b style='color:red'>2</b>O）<b style='color:red'>2</b>]·6<b style='color:red'>H</b><b style='color:red'>2</b>O](/image/thesis15 "Synthesis,Structure and Characterization of Two—dimensional Network Copper Complex [Cu3（nta）<b style='color:red'>2</b>（azpy）<b style='color:red'>2</b>（<b style='color:red'>H</b><b style='color:red'>2</b>O）<b style='color:red'>2</b>]·6<b style='color:red'>H</b><b style='color:red'>2</b>O")
![Syntheses, Crystal Structures and Characterization of Two Zeotype Crystals of K4[Cr30（<b style='color:red'>H</b><b style='color:red'>2</b>O） 3（OOCH） 6] <b style='color:red'>2</b>[ P<b style='color:red'>2</b>W18O62]· 9.5<b style='color:red'>H</b><b style='color:red'>2</b> O and K4[ Cr3O（ <b style='color:red'>H</b><b style='color:red'>2</b>O）3（ OOCH）6 ]<b style='color:red'>2</b>[ <b style='color:red'>H</b>3 P<b style='color:red'>2</b> W17Co（<b style='color:red'>H</b><b style='color:red'>2</b>O） O61]· 20<b style='color:red'>H</b><b style='color:red'>2</b>O](/image/thesis16 "Syntheses, Crystal Structures and Characterization of Two Zeotype Crystals of K4[Cr30（<b style='color:red'>H</b><b style='color:red'>2</b>O） 3（OOCH） 6] <b style='color:red'>2</b>[ P<b style='color:red'>2</b>W18O62]· 9.5<b style='color:red'>H</b><b style='color:red'>2</b> O and K4[ Cr3O（ <b style='color:red'>H</b><b style='color:red'>2</b>O）3（ OOCH）6 ]<b style='color:red'>2</b>[ <b style='color:red'>H</b>3 P<b style='color:red'>2</b> W17Co（<b style='color:red'>H</b><b style='color:red'>2</b>O） O61]· 20<b style='color:red'>H</b><b style='color:red'>2</b>O")
![新型仲钨酸盐-B化合物[Na_<b style='color:red'>2</b>（<b style='color:red'>H</b>_<b style='color:red'>2</b>O）_（10）][Cu_4（<b style='color:red'>H</b>_<b style='color:red'>2</b>O）_（12）（<b style='color:red'>H</b>_<b style='color:red'>2</b>W_（12）O_（42））]·15<b style='color:red'>H</b>_<b style='color:red'>2</b>O体外抗肿瘤活性研究](/image/thesis18 "新型仲钨酸盐-B化合物[Na_<b style='color:red'>2</b>（<b style='color:red'>H</b>_<b style='color:red'>2</b>O）_（10）][Cu_4（<b style='color:red'>H</b>_<b style='color:red'>2</b>O）_（12）（<b style='color:red'>H</b>_<b style='color:red'>2</b>W_（12）O_（42））]·15<b style='color:red'>H</b>_<b style='color:red'>2</b>O体外抗肿瘤活性研究")
